Bluejay Diagnostics, Inc. (BJDX) vs Beyond Air, Inc. (XAIR)
Bluejay Diagnostics, Inc. and Beyond Air, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. is the larger, with a market value of $4.3M against $3.1M — 1.4× the size. Beyond Air, Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 1.2×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −435.7%) and the higher return on invested capital (0.00% vs −174.9%). Across the 14 metrics below, Bluejay Diagnostics, Inc. leads on 12 and Beyond Air, Inc. on 2.
Valuation
Profitability
| Metric | BJDX | XAIR | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 4.18% | 56.01% |
| Operating margin | 0.00% | (364.76%) | (15.03%) |
| Net margin | 0.00% | (435.71%) | (20.40%) |
| Free cash flow margin | 0.00% | (254.96%) | (7.24%) |
| Return on equity | (98.89%) | (505.67%) | (15.32%) |
| Return on assets | (81.07%) | (109.80%) | (19.72%) |
| Return on invested capital | 0.00% | (174.89%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack